Case number IPR2023-00722
Mylan Pharmaceuticals Inc. et al. v. Novo Nordisk A/S > Related Cases
| Number | Title | Filing date |
|---|---|---|
| 1:22-cv-00295 | Novo Nordisk Inc. et al v. Aurobindo Pharma USA, Inc. et al | Mar 4, 2022 |
| 1:22-cv-00023 | Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc. | Mar 18, 2022 |
| 1:22-md-03038 | In Re: Ozempic (Semaglutide) Patent Litigation | Aug 5, 2022 |
| 1:22-cv-01040 | Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc. | Aug 8, 2022 |
| 1:23-cv-00101 | Novo Nordisk Inc. et al v. Viatris Inc. et al | Jan 27, 2023 |
| 1:23-cv-00013 | Novo Nordisk, Inc. et al v. Viatris Inc. et al | Jan 27, 2023 |
